Published in Curr Opin Allergy Clin Immunol on February 01, 2008
T2R38 taste receptor polymorphisms underlie susceptibility to upper respiratory infection. J Clin Invest (2012) 2.66
Resveratrol ameliorates abnormalities of fluid and electrolyte secretion in a hypoxia-Induced model of acquired CFTR deficiency. Laryngoscope (2015) 0.98
Transepithelial ion transport is suppressed in hypoxic sinonasal epithelium. Laryngoscope (2011) 0.97
Microarray analysis of distinct gene transcription profiles in non-eosinophilic chronic sinusitis with nasal polyps. Am J Rhinol (2009) 0.86
HIF-1 expression is associated with CCL2 chemokine expression in airway inflammatory cells: implications in allergic airway inflammation. Respir Res (2012) 0.85
Hypoxia-mediated mechanism of MUC5AC production in human nasal epithelia and its implication in rhinosinusitis. PLoS One (2014) 0.81
Chronic Rhinosinusitis without Nasal Polyps. J Allergy Clin Immunol Pract (2016) 0.76
New insights into upper airway innate immunity. Am J Rhinol Allergy (2016) 0.75
Wheatgrass extract inhibits hypoxia-inducible factor-1-mediated epithelial-mesenchymal transition in A549 cells. Nutr Res Pract (2017) 0.75
Delayed anaphylaxis, angioedema, or urticaria after consumption of red meat in patients with IgE antibodies specific for galactose-alpha-1,3-galactose. J Allergy Clin Immunol (2008) 3.15
Design and baseline characteristics of the epidemiology and natural history of asthma: Outcomes and Treatment Regimens (TENOR) study: a large cohort of patients with severe or difficult-to-treat asthma. Ann Allergy Asthma Immunol (2004) 2.22
The extended IL-10 superfamily: IL-10, IL-19, IL-20, IL-22, IL-24, IL-26, IL-28, and IL-29. J Allergy Clin Immunol (2008) 2.19
Twelve-year survey of fatal reactions to allergen injections and skin testing: 1990-2001. J Allergy Clin Immunol (2004) 2.18
Apoptotic cell clearance by bronchial epithelial cells critically influences airway inflammation. Nature (2012) 2.18
Decision-making analysis for allergen immunotherapy versus nasal steroids in the treatment of nasal steroid-responsive allergic rhinitis. Am J Rhinol Allergy (2014) 1.98
The diagnosis and management of sinusitis: a practice parameter update. J Allergy Clin Immunol (2005) 1.88
Cysteinyl leukotriene expression in chronic hyperplastic sinusitis-nasal polyposis: importance to eosinophilia and asthma. J Allergy Clin Immunol (2003) 1.76
Immunologic messenger molecules: cytokines, interferons, and chemokines. J Allergy Clin Immunol (2009) 1.58
Risk factors associated with persistent airflow limitation in severe or difficult-to-treat asthma: insights from the TENOR study. Chest (2007) 1.47
Sinus computed tomography scan and markers of inflammation in vocal cord dysfunction and asthma. Ann Allergy Asthma Immunol (2003) 1.40
A 71-year-old man with anaphylaxis after eating grits. Allergy Asthma Proc (2012) 1.39
Consistently very poorly controlled asthma, as defined by the impairment domain of the Expert Panel Report 3 guidelines, increases risk for future severe asthma exacerbations in The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. J Allergy Clin Immunol (2009) 1.38
Molecular and cellular staging for the severity of chronic rhinosinusitis. Laryngoscope (2004) 1.38
Rhinosinusitis: developing guidance for clinical trials. J Allergy Clin Immunol (2006) 1.33
Aspirin sensitivity and severity of asthma: evidence for irreversible airway obstruction in patients with severe or difficult-to-treat asthma. J Allergy Clin Immunol (2005) 1.23
Comparison of viral load in individuals with and without asthma during infections with rhinovirus. Am J Respir Crit Care Med (2014) 1.23
Evidence for distinct histologic profile of nasal polyps with and without eosinophilia. Laryngoscope (2011) 1.17
3. Cytokines and chemokines. J Allergy Clin Immunol (2006) 1.15
Key findings and clinical implications from The Epidemiology and Natural History of Asthma: Outcomes and Treatment Regimens (TENOR) study. J Allergy Clin Immunol (2012) 1.14
Genetics and phenotyping in chronic sinusitis. J Allergy Clin Immunol (2011) 1.12
Differences in candidate gene association between European ancestry and African American asthmatic children. PLoS One (2011) 1.09
A new generation of hereditary angioedema treatments: remarkable advances clash with disturbing economic reality. Ann Allergy Asthma Immunol (2011) 1.09
Comparison of test devices for skin prick testing. J Allergy Clin Immunol (2005) 1.07
Concordant modulation of cysteinyl leukotriene receptor expression by IL-4 and IFN-gamma on peripheral immune cells. Am J Respir Cell Mol Biol (2007) 1.06
Novel cytokines and cytokine-producing T cells in allergic disorders. Allergy Asthma Proc (2011) 1.03
Characterization of interleukin-4-stimulated nasal polyp fibroblasts. Am J Respir Cell Mol Biol (2003) 1.03
Characterization of a novel human mast cell line that responds to stem cell factor and expresses functional FcεRI. J Allergy Clin Immunol (2011) 1.02
Functional analysis of -571 IL-10 promoter polymorphism reveals a repressor element controlled by sp1. J Immunol (2004) 1.01
Assessment of asthma control and asthma exacerbations in the epidemiology and natural history of asthma: outcomes and treatment regimens (TENOR) observational cohort. Curr Respir Care Rep (2012) 1.01
The failure of interleukin-10-deficient mice to develop airway hyperresponsiveness is overcome by respiratory syncytial virus infection in allergen-sensitized/challenged mice. Am J Respir Crit Care Med (2002) 1.00
Chronic hyperplastic eosinophilic sinusitis as a predictor of aspirin-exacerbated respiratory disease. Ann Allergy Asthma Immunol (2005) 0.99
Modulation of T-cell function by (R)- and (S)-isomers of albuterol: anti-inflammatory influences of (R)-isomers are negated in the presence of the (S)-isomer. J Allergy Clin Immunol (2002) 0.97
Assessment of the lung microstructure in patients with asthma using hyperpolarized 3He diffusion MRI at two time scales: comparison with healthy subjects and patients with COPD. J Magn Reson Imaging (2008) 0.97
Sino-nasal outcome test (SNOT-22): a predictor of postsurgical improvement in patients with chronic sinusitis. Ann Allergy Asthma Immunol (2013) 0.97
Hypoxia stimulates inflammatory and fibrotic responses from nasal-polyp derived fibroblasts. Laryngoscope (2007) 0.96
Pathogenesis of rhinovirus infection. Curr Opin Virol (2012) 0.96
Trends in common rhinologic illnesses: analysis of U.S. healthcare surveys 1995-2007. Int Forum Allergy Rhinol (2010) 0.96
Prominent role of IFN-γ in patients with aspirin-exacerbated respiratory disease. J Allergy Clin Immunol (2013) 0.96
Rhinosinusitis: Developing guidance for clinical trials. Otolaryngol Head Neck Surg (2006) 0.95
5. Genetics of hypersensitivity. J Allergy Clin Immunol (2003) 0.95
Factors driving the aspirin exacerbated respiratory disease phenotype. Am J Rhinol Allergy (2015) 0.93
Chronic sinusitis pathophysiology: the role of allergy. Am J Rhinol Allergy (2013) 0.93
Allergy, total serum immunoglobulin E, and airflow in children and adolescents in TENOR. Pediatr Allergy Immunol (2010) 0.88
Dual action of TGF-beta1 on nasal-polyp derived fibroblasts. Laryngoscope (2008) 0.88
Pressure ulcer prevention. J Long Term Eff Med Implants (2004) 0.88
Chronic rhinosinusitis and antibiotics: the good, the bad, and the ugly. Am J Rhinol Allergy (2013) 0.88
Lack of a role for cross-reacting anti-thyroid antibodies in chronic idiopathic urticaria. J Invest Dermatol (2010) 0.87
Microarray analysis of distinct gene transcription profiles in non-eosinophilic chronic sinusitis with nasal polyps. Am J Rhinol (2009) 0.86
5. Genetics of allergic disease. J Allergy Clin Immunol (2008) 0.85
High prevalence of skin test positivity in severe or difficult-to-treat asthma. J Asthma (2006) 0.85
Massive soft tissue infections: necrotizing fasciitis and purpura fulminans. J Long Term Eff Med Implants (2005) 0.84
Modulation by aspirin of nuclear phospho-signal transducer and activator of transcription 6 expression: Possible role in therapeutic benefit associated with aspirin desensitization. J Allergy Clin Immunol (2009) 0.83
Leukotriene receptors in rhinitis and sinusitis. Curr Allergy Asthma Rep (2004) 0.83
Expression of leukotriene C4 synthase and plasminogen activator inhibitor 1 gene promoter polymorphisms in sinusitis. Am J Rhinol (2006) 0.83
Etiology of nasal polyps in cystic fibrosis: not a unimodal disease. Ann Otol Rhinol Laryngol (2012) 0.83
Interleukin-4 in the Generation of the AERD Phenotype: Implications for Molecular Mechanisms Driving Therapeutic Benefit of Aspirin Desensitization. J Allergy (Cairo) (2012) 0.82
Cysteinyl leukotrienes in chronic hyperplastic rhinosinusitis. Otolaryngol Head Neck Surg (2002) 0.82
Fifty-five-year-old man with chronic yeast infections. Allergy Asthma Proc (2014) 0.81
Management of hereditary angioedema in 2012: scientific and pharmacoeconomic perspectives. Ann Allergy Asthma Immunol (2012) 0.81
The role of allergy in chronic rhinosinusitis. Immunol Allergy Clin North Am (2004) 0.80
IL-4 and IL-13 dual antagonism: a promising approach to the dilemma of generating effective asthma biotherapeutics. Am J Respir Crit Care Med (2010) 0.80
Differential interleukin-10 production stratified by -571 promoter polymorphism in purified human immune cells. Cell Immunol (2008) 0.80
Genetics of allergic disease. Med Clin North Am (2006) 0.79
Epidemiological analysis of chronic rhinitis in pediatric patients. Am J Rhinol Allergy (2011) 0.79
Corticosteroids as inhibitors of cysteinyl leukotriene metabolic and signaling pathways. J Allergy Clin Immunol (2008) 0.79
Perioperative anaphylaxis in a 44-year-old man. Allergy Asthma Proc (2007) 0.78
Opposing actions of (R,R)-isomers and (S,S)-isomers of formoterol on T-cell function. J Allergy Clin Immunol (2006) 0.78
Local class switching in nonallergic rhinitis. Curr Opin Otolaryngol Head Neck Surg (2011) 0.77
Identification of an Sp factor-dependent promoter in GCET, a gene expressed at high levels in germinal center B cells. Mol Immunol (2004) 0.76
Endothelin-1: a useful marker for asthmatic inflammation? Ann Allergy Asthma Immunol (2002) 0.75
Aspirin-exacerbated respiratory disease: Prevalence, diagnosis, treatment, and considerations for the future. Am J Rhinol Allergy (2016) 0.75
Failure of itraconazole to prevent T-helper type 2 cell immune deviation: Implications for chronic rhinosinusitis. Am J Rhinol Allergy (2016) 0.75
Update on allergy immunotherapy. Allergy Asthma Clin Immunol (2005) 0.75
Calcium phosphate bone cements: a comprehensive review. J Long Term Eff Med Implants (2003) 0.75
Response. Am J Rhinol Allergy (2014) 0.75
Common variable immunodeficiency presenting as herpes simplex virus encephalitis. J Allergy Clin Immunol (2010) 0.75
Autoimmune mechanisms in chronic idiopathic urticaria. J Allergy Clin Immunol (2012) 0.75
The promise and obstacles of asthma genetics research. Ann Allergy Asthma Immunol (2012) 0.75
Chapter 16: Determining the role of allergy in sinonasal disease. Am J Rhinol Allergy (2013) 0.75
Proinflammatory effects of IL-4 antagonism. J Allergy Clin Immunol (2006) 0.75
Chapter 17: Immunomodulation of allergic sinonasal disease. Am J Rhinol Allergy (2013) 0.75
Latex allergy: a life-threatening epidemic for scientists, healthcare personnel, and their patients. J Long Term Eff Med Implants (2003) 0.75
Update on reconstructive options for nasal Mohs defects 1.5 cm or less. Curr Opin Otolaryngol Head Neck Surg (2016) 0.75
Surgical Correction of an Extensive Skull Base Defect as a Result of Pneumocele. J Craniofac Surg (2016) 0.75
Chapter 16: Determining the role of allergy in sinonasal disease. Am J Rhinol Allergy (2013) 0.75
Chapter 17: Immunomodulation of allergic sinonasal disease. Am J Rhinol Allergy (2013) 0.75